Abstract Details
|
Sohaila A. Alshimemeri, MD
(King Saud University)
PRESENTER |
Dr. Alshimemeri has nothing to disclose. |
| No disclosure on file | |
| Lily Zhou, MD (Vancouver General Hospital) | Dr. Zhou has received research support from Canadian Institute of Health Research. |
| Sarah Furtado, MD, PhD, FRCPC (Dept of Clinical Neurosciences) | Dr. Furtado has nothing to disclose. |
| Scott W. Kraft, MD | An immediate family member of Dr. Kraft has received personal compensation for serving as an employee of Bayer. An immediate family member of Dr. Kraft has received stock or an ownership interest from Bayer . |
| Veronica A. Bruno, MD (University of Calgary Foothills) | Dr. Bruno has nothing to disclose. |
| Antoine Duquette, MD (CHUM) | Dr. Duquette has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Reata. The institution of Dr. Duquette has received research support from Actelion. The institution of Dr. Duquette has received research support from Ataxia Canada/FARA. |
| Bernard Brais, MD (Montreal Neurological Institute-Hospital) | Dr. Brais has nothing to disclose. |
| Oksana Suchowersky, MD, FAAN (University of Alberta Hospital) | Dr. Suchowersky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Syneos/Alexion. The institution of Dr. Suchowersky has received research support from Roche. The institution of Dr. Suchowersky has received research support from Wave LifeSciences. The institution of Dr. Suchowersky has received research support from CHDI. Dr. Suchowersky has received publishing royalties from a publication relating to health care. Dr. Suchowersky has received publishing royalties from a publication relating to health care. |
| Renato P. Munhoz, MD, PhD | Dr. Munhoz has nothing to disclose. |
| Elizabeth Slow, MD, PhD | Dr. Slow has nothing to disclose. |